LEADER 02803nam  2200397   450 
001 9910645953403321
005 20230325055121.0
010   $a9780520388727
024 7 $a10.1525/9780520388727
035   $a(CKB)5860000000285395
035   $a(NjHacI)995860000000285395
035   $a(DE-B1597)627970
035   $a(DE-B1597)9780520388727
035   $a(EXLCZ)995860000000285395
100   $a20230325d2023      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCapitalizing a Cure $ehow finance controls the price and value of medicines /$fVictor Roy
210  1$aOakland, California :$cUniversity of California Press,$d2023.
215   $a1 online resource
311   $a0-520-38871-2 
327   $aPreface : pandemics, Wall Street, and the value playbook -- Introduction : the politics of drug pricing and the value of a cure -- Capitalizing science : public knowledge into pharmaceutical assets -- Capitalizing drugs : shareholder power and the cannibalizing company -- Capitalizing health : the struggle over value and treatment access -- From financialization to public purpose for health -- Conclusion : reckoning with pharmaceutical value in crisis times.
330   $a"Capitalizing a Cure takes us into the struggle over accessing a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When sofosbuvir-based medicines launched in 2013, they promised a cure for millions of patients worldwide with hepatitis C. But their sticker shock-the drug was dubbed "the $1,000-a-day pill"-intensified a global debate over the pricing of new medicines. Weaving extensive historical research with insights from political economy and science and technology studies, Victor Roy demystifies an oft-missed dynamic in this debate: the reach of financialized capitalism into how medicines are made, priced, and valued. His account travels between public and private labs, Wall Street and corporate boardrooms, public health meetings and health centers to trace the ways sofosbuvir-based medicines became financial assets dominated by strategies of speculation and extraction at the expense of access and care. Provocative and sobering, this book illuminates the harmful impact of allowing financial markets to supersede democracy and human health and points to the necessary work of building more equitable futures."--$cProvided by publisher.
606   $aDrugs$xPrices$zUnited States
615  0$aDrugs$xPrices
676   $a338.4361510973
700   $aRoy$b Victor$01347662
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910645953403321
996   $aCapitalizing a Cure$93084226
997   $aUNINA